Developer docs
API playgroundTry for free, no card

Search company profiles

Esper Bionics

Full company profile

uuid0000boz

Namestring
Esper Bionics
Legal namestring
Esper Bionics Inc.
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Esper Bionics is a Ukrainian-American engineering company founded in 2019 that designs and manufactures AI-driven bionic prosthetic hands for upper-limb amputees. The company is headquartered in Brooklyn, New York, with R&D and production in Kyiv, Ukraine, and a manufacturing and R&D facility in Berlin, Germany. Its core product, the Esper Hand, is a multi-actuator bionic prosthetic that uses electromyography (EMG) sensors combined with machine learning and COAPT pattern recognition to predict user movement intentions and automatically select appropriate grips; the second-generation Esper Hand 2, launched in May 2025, adds IP6X waterproofing, aluminum fingers, extended battery life, and on-device AI. The proprietary MARS multisensory hub is positioned as the underlying control platform for prosthetics and future wearables, and the Esper+ mobile app provides Bluetooth-based grip customization, sensor tuning, and usage analytics.

The business model is anchored on hardware sales of the Esper Hand at a $22,000 price point, with US insurance reimbursement enabled by FDA approval and PDAC billing code L6880. Distribution combines direct enterprise sales to patients, a clinic and prosthetist partnership program, and the Esper+ self-serve companion app; the company has explicitly identified sensor technology licensing to other wearable and implant manufacturers as a future revenue stream. The customer base spans individual upper-limb amputees (civilian and military), prosthetists and clinics as channel partners, and Ukrainian war veterans served through the non-commercial Esper for Ukraine social program, which has delivered more than 80 devices since 2022. Strategic capital partners include YZR Capital, EBRD, and U.Ventures following a $5M round in June 2024, bringing total funding to approximately $7M, with the US identified as the primary commercial market ahead of global expansion.

Short descriptiontext

Esper Bionics designs and manufactures AI-driven bionic prosthetic hands for upper-limb amputees, combining EMG-based machine learning with a multisensory MARS control hub and an Esper+ companion app. The company sells the $22,000 Esper Hand through US clinics, insurance reimbursement, and a prosthetist partnership network, with secondary social distribution to Ukrainian veterans.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
bionic prosthetics, AI prosthetic devices, EMG pattern recognition, upper limb prosthetics, assistive medical devices
Industry3 codes
PRIMARYHLAHAEAH
Limb Prosthetics (Upper/Lower Extremity Prosthetic Systems)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAHAMAD
Prosthetic Components & Rehabilitation Accessories (Liners, Feet, Knees, Sockets)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Rehabilitation & Mobility Aids (DME)
SECONDARYHSADAIAN
Prosthetics/Orthotics Rehab & Amputee Rehabilitation
Home & Personal Services/Fitness, Wellness & Personal Training/Physical Therapy, Rehabilitation & Corrective Exercise
NAICS code2 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Bionic Prosthetics
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Bionic Prosthetic Device Sales
TypeHardware Sales
Description

Sale of AI-powered bionic prosthetic hands (Esper Hand) to patients. Primary revenue stream from hardware sales with Esper Hand priced at $22,000 and covered by insurance.

sifted.eu
2Sensor Technology Licensing
TypeLicensing Royalties
Description

Future revenue expected from licensing advanced sensors developed for prosthetic devices to other wearable technology and implant manufacturers.

sifted.eu
3MARS Control System
TypeHardware Sales
Description

Sales of MARS control system hub enabling high-precision control for prosthetics and wearables, part of expanding bionic ecosystem product line.

sifted.eu
4Clinical Services and Support
TypeProfessional Services
Description

Clinical onboarding, training, and ongoing support services for prosthetists and clinics implementing Esper Hand devices.

esperbionics.com
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Pricing details2 tiers
1Esper Hand - Standard Configuration
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Esper Hand priced at $22,000. Covered by US insurance providers. Medical necessity criteria and billing codes (L6880) apply for insurance coverage.

en.ain.ua
2Esper Hand 2 - Upgraded Version
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Second generation device featuring water resistance, enhanced grip with aluminum fingers, larger touch surfaces, extended battery life, and integrated AI-based pattern recognition.

esperbionics.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1Esper Hand
Description

AI-powered bionic prosthetic hand with pattern recognition, waterproof design, and anatomical shape

esperbionics.com
+3 more records
Core offering1 text field

Esper Bionics designs, manufactures, and sells AI-driven bionic prosthetic hands (Esper Hand and Esper Hand 2) for upper-limb amputees, priced at $22,000 and covered by US insurance. The offering centers on the Esper Hand product line with integrated EMG-based pattern recognition, complemented by the MARS multisensory control hub and the Esper+ mobile app for grip customization. Distribution occurs through direct sales, clinic/prosthetist partnerships, and a social program providing free prostheses to Ukrainian war veterans.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 4 hours average daily usage demonstrating consistent real-world adoption
+5 more records
Product overview1 text field

Esper Bionics offers a unified bionic ecosystem centered on the Esper Hand product line. The core offering is the AI-powered Esper Hand bionic prosthetic (now in its second generation), which combines advanced EMG-based pattern recognition with a smartphone companion app (Esper+) for customization. The MARS multisensory hub serves as the underlying control platform enabling high-precision body parameter detection and control. The company has developed the world's first AI-driven prosthetic with PDAC and FDA approvals, targeting both medical (amputees) and military markets with products priced at approximately $22,000.

Product and service4 records
1Esper Hand
CategoryBionic Prosthetic Hand
Description

The world's first AI-driven bionic prosthetic hand with PDAC (L6880) and FDA approvals. Features pattern-recognition control, waterproof design, aluminum-reinforced fingers, six independent motors for natural movement, and integration with the Esper+ mobile app for customization. Sold at $22,000 and covered by US insurance, targeting upper-limb amputees through clinics and direct sales.

2Esper Hand 2
CategoryBionic Prosthetic Hand
Description

Second-generation AI-powered bionic prosthetic hand with IP6X waterproof rating, enhanced grip strength via aluminum fingers, larger touchscreen surfaces, extended all-day battery life, and integrated AI-based pattern recognition using EMG sensors for smoother, more natural operation. Pre-orders opened in May 2025.

3MARS Control System
CategoryProsthetic Control System
Description

Advanced EMG-based multisensory hub enabling detection of body parameters and high-precision control in prosthetics and wearables. Lays the foundation for a future preventive-medicine body health insights platform and is positioned as part of an expanding bionic ecosystem product line.

4Esper+ Mobile App
CategoryCompanion Mobile Application
Description

iOS mobile application for users to customize grips, organize settings, fine-tune sensors, back up configurations via Bluetooth, switch commands, and track usage statistics including grip patterns and daily engagement metrics. Designed as the digital companion to the Esper Hand product line.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
1COAPT
Strategic tierCoreTypeTechnology or Integration
Description

Technology partner providing pattern recognition functionality integrated into Esper Hand for direct access to intended grip. COAPT technology enables the system to recognize user movements and automatically switch to appropriate grip mode.

esperbionics.com
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Collaboration with Razom and Ukrainian clinics to expand access to advanced prosthetic care for people with limb loss in Ukraine. Initiative supports the entire care pathway from assessment to long-term follow-up and aims to strengthen Ukraine's prosthetics ecosystem.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Partnership with Ukrainian clinics for prosthetic care delivery, assessment, fitting, and long-term follow-up services. Focus on developing and educating specialists in modern bionic solutions to improve rehabilitation and accessibility.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Partner organization in Ukraine working to provide prosthetic solutions for war-affected individuals.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Partner organization supporting Ukrainian defenders and civilians with prosthetic and rehabilitation needs.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Partner organization providing prosthetics and rehabilitation services for war veterans and civilians.

7Bez Obmezhen'
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Ukrainian organization supporting people with disabilities and limb loss.

esperbionics.com
8Brave Step
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Partner organization in Ukrainian prosthetics ecosystem.

esperbionics.com
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Partner organization supporting rehabilitation and prosthetics for war-affected individuals.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Partner organization supporting Ukrainian military personnel with prosthetic needs.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Direct competitor building multi-grip bionic prosthetic hands (Hero Arm) using 3D-printed components and EMG control, with FDA clearance and a similar insurance-reimbursement-driven US go-to-market.

TypeDirect peer
Description

Direct competitor whose Ability Hand is a multi-grip bionic prosthetic with touch-sensing fingertips targeting upper-limb amputees, closely overlapping Esper Hand's product positioning and customer base.

TypeBroad incumbent
Description

Broad incumbent in orthotics and prosthetics offering the i-Limb Quantum bionic hand, with established global distribution, deeper payer relationships, and a much wider product portfolio than Esper.

TypeBroad incumbent
Description

Largest global prosthetics incumbent offering the bebionic multi-grip hand, with extensive clinical infrastructure, reimbursement expertise, and significant R&D resources.

TypeDirect peer
Description

Developer of the LUKE shoulder-level bionic arm with EMG pattern recognition, addressing a higher level of upper-limb amputation but in the same AI-driven prosthetic category as Esper Hand.

TypeEmerging player
Description

Italian robotics startup producing the IH2 Azzurra and Mia Hand bionic prosthetic hands using EMG signals, representing a smaller emerging competitor with overlapping technical approach.

7COAPT
TypeOthers
Description

Strategic technology partner supplying the pattern recognition engine integrated into Esper Hand; also sells its own Complete Control system to other prosthetic manufacturers, making it both an enabler and partial adjacent competitor.

TypeEmerging player
Description

Brain-computer interface company developing prosthetic control technologies using EMG/EEG signals, intersecting with Esper's EMG-based control approach at the R&D and technology-stack level.

TypeBroad incumbent
Description

Established prosthetics manufacturer offering a broad range of upper- and lower-limb prosthetic components, including terminal devices and control systems used by prosthetists — comparable downstream channel partner.

TypeRegional player
Description

UK-based prosthetics manufacturer with a multi-grip bionic hand product line and established prosthetist distribution in Europe, offering a regionally comparable competitor outside Esper's primary US/Ukraine footprint.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds8 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Esper Bionics

Bionic Prostheticsesperbionics.com

Esper Bionics designs and manufactures AI-driven bionic prosthetic hands for upper-limb amputees, combining EMG-based machine learning with a multisensory MARS control hub and an Esper+ companion app. The company sells the $22,000 Esper Hand through US clinics, insurance reimbursement, and a prosthetist partnership network, with secondary social distribution to Ukrainian veterans.

What Esper Bionics does

Esper Bionics is a Ukrainian-American engineering company founded in 2019 that designs and manufactures AI-driven bionic prosthetic hands for upper-limb amputees. The company is headquartered in Brooklyn, New York, with R&D and production in Kyiv, Ukraine, and a manufacturing and R&D facility in Berlin, Germany. Its core product, the Esper Hand, is a multi-actuator bionic prosthetic that uses electromyography (EMG) sensors combined with machine learning and COAPT pattern recognition to predict user movement intentions and automatically select appropriate grips; the second-generation Esper Hand 2, launched in May 2025, adds IP6X waterproofing, aluminum fingers, extended battery life, and on-device AI. The proprietary MARS multisensory hub is positioned as the underlying control platform for prosthetics and future wearables, and the Esper+ mobile app provides Bluetooth-based grip customization, sensor tuning, and usage analytics.

The business model is anchored on hardware sales of the Esper Hand at a $22,000 price point, with US insurance reimbursement enabled by FDA approval and PDAC billing code L6880. Distribution combines direct enterprise sales to patients, a clinic and prosthetist partnership program, and the Esper+ self-serve companion app; the company has explicitly identified sensor technology licensing to other wearable and implant manufacturers as a future revenue stream. The customer base spans individual upper-limb amputees (civilian and military), prosthetists and clinics as channel partners, and Ukrainian war veterans served through the non-commercial Esper for Ukraine social program, which has delivered more than 80 devices since 2022. Strategic capital partners include YZR Capital, EBRD, and U.Ventures following a $5M round in June 2024, bringing total funding to approximately $7M, with the US identified as the primary commercial market ahead of global expansion.

Esper Bionics firmographics

Firmographics
Name
Esper Bionics
Legal name
Esper Bionics Inc.
Website
https://esperbionics.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
51–100 employees
Short description
Esper Bionics designs and manufactures AI-driven bionic prosthetic hands for upper-limb amputees, combining EMG-based machine learning with a multisensory MARS control hub and an Esper+ companion app. The company sells the $22,000 Esper Hand through US clinics, insurance reimbursement, and a prosthetist partnership network, with secondary social distribution to Ukrainian veterans.
Ownership category
akta.pro rank

Esper Bionics industry classification

Industry
Product category
Bionic Prosthetics
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHAEAH
Limb Prosthetics (Upper/Lower Extremity Prosthetic Systems)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHLAHAMAD
Prosthetic Components & Rehabilitation Accessories (Liners, Feet, Knees, Sockets)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Rehabilitation & Mobility Aids (DME)
SECONDARYHSADAIAN
Prosthetics/Orthotics Rehab & Amputee Rehabilitation
Home & Personal Services/Fitness, Wellness & Personal Training/Physical Therapy, Rehabilitation & Corrective Exercise

Keywords

  • Bionic prosthetics
  • AI prosthetic devices
  • EMG pattern recognition
  • Upper limb prosthetics
  • Assistive medical devices

Where Esper Bionics is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Esper Bionics business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. Bionic Prosthetic Device Sales: Sale of AI-powered bionic prosthetic hands (Esper Hand) to patients. Primary revenue stream from hardware sales with Esper Hand priced at $22,000 and covered by insurance.
  2. Sensor Technology Licensing: Future revenue expected from licensing advanced sensors developed for prosthetic devices to other wearable technology and implant manufacturers.
  3. MARS Control System: Sales of MARS control system hub enabling high-precision control for prosthetics and wearables, part of expanding bionic ecosystem product line.
  4. Clinical Services and Support: Clinical onboarding, training, and ongoing support services for prosthetists and clinics implementing Esper Hand devices.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goEsper Hand - Standard Configuration
One time/ perpetual licensePay-as-you-goEsper Hand 2 - Upgraded Version

Go-to-market motion3 records

Distribution channels5 records

Marketing channels10 records

Esper Bionics product offering

Product offering

Core offering

Esper Bionics designs, manufactures, and sells AI-driven bionic prosthetic hands (Esper Hand and Esper Hand 2) for upper-limb amputees, priced at $22,000 and covered by US insurance. The offering centers on the Esper Hand product line with integrated EMG-based pattern recognition, complemented by the MARS multisensory control hub and the Esper+ mobile app for grip customization. Distribution occurs through direct sales, clinic/prosthetist partnerships, and a social program providing free prostheses to Ukrainian war veterans.

Product overview

Esper Bionics offers a unified bionic ecosystem centered on the Esper Hand product line. The core offering is the AI-powered Esper Hand bionic prosthetic (now in its second generation), which combines advanced EMG-based pattern recognition with a smartphone companion app (Esper+) for customization. The MARS multisensory hub serves as the underlying control platform enabling high-precision body parameter detection and control. The company has developed the world's first AI-driven prosthetic with PDAC and FDA approvals, targeting both medical (amputees) and military markets with products priced at approximately $22,000.

Differentiator

Problem solved

Functional benefit

Brands

  • Esper Hand: AI-powered bionic prosthetic hand with pattern recognition, waterproof design, and anatomical shape
  • MARS
  • Esper for Ukraine
  • Esper+

Products and services

  • Esper Hand The world's first AI-driven bionic prosthetic hand with PDAC (L6880) and FDA approvals. Features pattern-recognition control, waterproof design, aluminum-reinforced fingers, six independent motors for natural movement, and integration with the Esper+ mobile app for customization. Sold at $22,000 and covered by US insurance, targeting upper-limb amputees through clinics and direct sales.
  • Esper Hand 2 Second-generation AI-powered bionic prosthetic hand with IP6X waterproof rating, enhanced grip strength via aluminum fingers, larger touchscreen surfaces, extended all-day battery life, and integrated AI-based pattern recognition using EMG sensors for smoother, more natural operation. Pre-orders opened in May 2025.
  • MARS Control System Advanced EMG-based multisensory hub enabling detection of body parameters and high-precision control in prosthetics and wearables. Lays the foundation for a future preventive-medicine body health insights platform and is positioned as part of an expanding bionic ecosystem product line.
  • Esper+ Mobile App iOS mobile application for users to customize grips, organize settings, fine-tune sensors, back up configurations via Bluetooth, switch commands, and track usage statistics including grip patterns and daily engagement metrics. Designed as the digital companion to the Esper Hand product line.

Quantifiable outcome

  • 4 hours average daily usage demonstrating consistent real-world adoption
  • +5 more outcomes

Companies that use Esper Bionics

Customer profile

Named customers11 records

Segments5 records

Ideal customer profiles3 records

Esper Bionics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability6 records

Feature9 records

Esper Bionics partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core, major and supporting.

  • COAPTcoreTechnology or IntegrationTechnology partner providing pattern recognition functionality integrated into Esper Hand for direct access to intended grip. COAPT technology enables the system to recognize user movements and automatically switch to appropriate grip mode.
  • RazommajorStrategic or Co-development PartnerCollaboration with Razom and Ukrainian clinics to expand access to advanced prosthetic care for people with limb loss in Ukraine. Initiative supports the entire care pathway from assessment to long-term follow-up and aims to strengthen Ukraine's prosthetics ecosystem.
  • Ukrainian ClinicsmajorStrategic or Co-development PartnerPartnership with Ukrainian clinics for prosthetic care delivery, assessment, fitting, and long-term follow-up services. Focus on developing and educating specialists in modern bionic solutions to improve rehabilitation and accessibility.
  • Protez FoundationsupportingStrategic or Co-development PartnerPartner organization in Ukraine working to provide prosthetic solutions for war-affected individuals.
  • UnbrokensupportingStrategic or Co-development PartnerPartner organization supporting Ukrainian defenders and civilians with prosthetic and rehabilitation needs.
  • SuperhumanssupportingStrategic or Co-development PartnerPartner organization providing prosthetics and rehabilitation services for war veterans and civilians.
  • Bez Obmezhen'supportingStrategic or Co-development PartnerUkrainian organization supporting people with disabilities and limb loss.
  • Brave StepsupportingStrategic or Co-development PartnerPartner organization in Ukrainian prosthetics ecosystem.
  • RevivedsupportingStrategic or Co-development PartnerPartner organization supporting rehabilitation and prosthetics for war-affected individuals.
  • Soldiers UkrainesupportingStrategic or Co-development PartnerPartner organization supporting Ukrainian military personnel with prosthetic needs.

Scale indicators8 records

Recent moves8 records

Expansion highlights6 records

Esper Bionics competitors and assessment

Company assessment

Direct peers

  • Open Bionics: Direct competitor building multi-grip bionic prosthetic hands (Hero Arm) using 3D-printed components and EMG control, with FDA clearance and a similar insurance-reimbursement-driven US go-to-market.
  • Psyonic: Direct competitor whose Ability Hand is a multi-grip bionic prosthetic with touch-sensing fingertips targeting upper-limb amputees, closely overlapping Esper Hand's product positioning and customer base.
  • Mobius Bionics: Developer of the LUKE shoulder-level bionic arm with EMG pattern recognition, addressing a higher level of upper-limb amputation but in the same AI-driven prosthetic category as Esper Hand.

Broad incumbents

  • Össur (Touch Bionics): Broad incumbent in orthotics and prosthetics offering the i-Limb Quantum bionic hand, with established global distribution, deeper payer relationships, and a much wider product portfolio than Esper.
  • Ottobock: Largest global prosthetics incumbent offering the bebionic multi-grip hand, with extensive clinical infrastructure, reimbursement expertise, and significant R&D resources.
  • Fillauer: Established prosthetics manufacturer offering a broad range of upper- and lower-limb prosthetic components, including terminal devices and control systems used by prosthetists — comparable downstream channel partner.

Emerging players

  • Prensilia: Italian robotics startup producing the IH2 Azzurra and Mia Hand bionic prosthetic hands using EMG signals, representing a smaller emerging competitor with overlapping technical approach.
  • BrainCo: Brain-computer interface company developing prosthetic control technologies using EMG/EEG signals, intersecting with Esper's EMG-based control approach at the R&D and technology-stack level.

Others

  • COAPT: Strategic technology partner supplying the pattern recognition engine integrated into Esper Hand; also sells its own Complete Control system to other prosthetic manufacturers, making it both an enabler and partial adjacent competitor.

Regional players

  • Steeper Group: UK-based prosthetics manufacturer with a multi-grip bionic hand product line and established prosthetist distribution in Europe, offering a regionally comparable competitor outside Esper's primary US/Ukraine footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

Esper Bionics social profiles

Digital presence

Esper Bionics compliance and trust

Trust signal

Compliance2 records

Esper Bionics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Esper Bionics leadership team

Management profile

Number of profiles

Profiles2 records

Esper Bionics funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Esper Bionics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Esper Bionics

What does Esper Bionics do?

Esper Bionics designs, manufactures, and sells AI-driven bionic prosthetic hands (Esper Hand and Esper Hand 2) for upper-limb amputees, priced at $22,000 and covered by US insurance. The offering centers on the Esper Hand product line with integrated EMG-based pattern recognition, complemented by the MARS multisensory control hub and the Esper+ mobile app for grip customization. Distribution occurs through direct sales, clinic/prosthetist partnerships, and a social program providing free prostheses to Ukrainian war veterans.

Is Esper Bionics a public or private company?

Esper Bionics is a private company. It is classified as venture growth investor backed and is currently operating.

When was Esper Bionics founded?

Esper Bionics was founded in 2019. It employs 51 to 100 people.

Where is Esper Bionics based?

Esper Bionics is headquartered in New York, United States, in the North America region.

How does Esper Bionics make money?

Four revenue lines are on record. Bionic Prosthetic Device Sales are the primary driver. The others are sensor Technology Licensing, MARS Control System and clinical Services and Support.

Who are Esper Bionics's main competitors?

Direct peers on record are Open Bionics, Psyonic and Mobius Bionics. Broad incumbents are Össur (Touch Bionics), Ottobock and Fillauer. Emerging players are Prensilia and BrainCo. COAPT is listed as an others. Steeper Group is listed as a regional player.

Does Esper Bionics have an API?

No public API is recorded for Esper Bionics.

What industry is Esper Bionics in?

Esper Bionics's product category is Bionic Prosthetics. Its primary akta.pro industry code is HLAHAEAH, Limb Prosthetics (Upper/Lower Extremity Prosthetic Systems), with a secondary code of HLAHAMAD, Prosthetic Components & Rehabilitation Accessories (Liners, Feet, Knees, Sockets). Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
New ScientistHow Ukraine created world-leading prostheses amid the chaos of warUkraine has developed advanced prosthetics amid war, with government paying $100,000 per limb. Companies like Esper and Protez Foundation fit devices, but shortages of trained clinicians and ethical concerns persist. The industry may export expertise, but accessibility remains a challenge.LinkedInEsper BionicsEsper Bionics, a Ukrainian company specializing in bionic prosthetic limbs, is engaged in multiple initiatives including expanding access to prosthetic care in Ukraine and developing advanced AI-driven prosthetic hands. The company collaborates with Ukrainian clinics, educational programs, and international partners to improve functionality and aesthetics of prosthetic devices.EsperbionicsEsperEsper Bionics is promoting its Esper Hand, a myoelectric bionic prosthetic device that has received PDAC approval for L6880 reimbursement. The product features six independent motors, water-resistant design, and customizable aesthetics to improve patient adoption and clinical efficiency.Request BlockedCrisis response and resilienceThe EBRD outlines its crisis response and resilience approach, focusing on preserving human capital and supporting livelihoods. It highlights a US$1.25 million equity investment in Esper Bionics, a Ukrainian prosthetics company, to expand production and training. The bank plans to deepen engagement in Ukraine and other fragile places.openPR.comSegment Analysis and Major Growth Areas in the Artificial Intelligence (AI)-Driven Prosthetics MarketThe AI-powered prosthetics market is projected to grow to $3.57 billion by 2030, representing a compound annual growth rate of 15.9%, driven by advances in AI and machine learning, increased investments in robotic and myoelectric prosthetic technologies, and rising demand from sports and military sectors. In February 2024, Nippon Express Holdings acquired a stake in Instalimb Inc. to facilitate the latter's global growth and improve access to affordable AI-powered 3D-printed prosthetics in emerging markets through enhanced logistics. In May 2025, Ukraine-based Esper Bionics unveiled the Esper Hand 2, an AI-powered waterproof prosthetic hand that adapts to user behavior and delivers enhanced grip strength.citybizSerhii Tokarev Explained Why Ukraine Is Becoming a Global Healthtech FrontierIT investor Serhii Tokarev explains how Russia's full-scale invasion has transformed Ukraine into a global healthtech frontier, with the sector raising over $300 million in 2024 funding rounds including a $5 million round for bionics company Esper Bionics. Ukrainian startups including Helsi (29 million registered patients), rehabilitation firms SYLA and ComeBack Mobility, mental health platform Mindly, and VR therapy developer Aspichi are delivering results in trauma care, prosthetics, logistics, and mental health. Tokarev argues that innovations developed under Ukraine's extreme conditions can serve as models for global healthcare.MainUkraine Emerges as a Global Healthtech Innovation HubTech.eu has published an analysis highlighting Ukraine's emergence as a global healthtech innovation hub, with companies like Esper Bionics, Liki24, and ComeBack Mobility developing solutions for mental health, prosthetics, and digital healthcare at record speed amid wartime conditions. The Ukrainian healthtech sector raised over $300 million across the top ten funding rounds in 2024, with Liki24 reporting 70% of its revenue now coming from the EU after doubling domestic revenue, while companies like ComeBack Mobility and Luminify have successfully expanded to the US market. The article attributes this growth to a combination of deep technical expertise, pre-invasion digital infrastructure, and support from local incubators, venture funds including u.ventures and Horizon Capital, and global programs.Tech.euWhy Ukraine is becoming a global healthtech frontierUkraine's full-scale war has transformed the country into a healthtech innovation hub, with startups developing solutions for trauma care, mental health, rehabilitation, and healthcare logistics under extreme conditions. Key funding includes Liki24 raising €9 million (total €19 million) and Esper Bionics securing $5 million, while platforms like Helsi serve 29 million registered patients and Mindly reached 3,000 users within three weeks of pivoting. The article argues that solutions built under Ukraine's extreme conditions are proving competitive globally and attracting international investment, with Liki24 growing EU revenue from 35-40% to 70% of total revenue.YahooArtificial Intelligence (AI)-Powered Prosthetics Market Research Report 2025-2029 & 2034: Strong Growth Forecast as Neural Interfaces, Personalization, and Smart Materials Transform Mobility SolutionsThe AI-powered prosthetics market is projected to grow from $1.47 billion in 2024 to $3.08 billion in 2029, driven by rising diabetes-related amputations, advancements in neural interface technology, and increasing adoption of myoelectric and 3D-printed prosthetics. Esper Bionics launched its AI-powered Esper Hand 2 prosthetic in May 2025, while Nippon Express Holdings acquired an equity stake in Japan-based startup Instalimb Inc. in February 2024 to support global expansion of affordable AI-driven 3D-printed prosthetic devices. North America remains the largest regional market, with Asia-Pacific expected to be the fastest-growing region through the forecast period.GlobeNewswireArtificial Intelligence (AI)-Powered Prosthetics Market Research Report 2025-2029 & 2034: Strong Growth Forecast as Neural Interfaces, Personalization, and Smart Materials Transform Mobility SolutionsThe global AI-powered prosthetics market is projected to grow from $1.71 billion in 2025 to $3.08 billion by 2029, representing a compound annual growth rate of 15.9%, driven by rising diabetes-related amputations, adoption of myoelectric prosthetics, and advances in neural control interfaces. Esper Bionics launched the AI-powered, waterproof Esper Hand 2 in May 2025, while Nippon Express Holdings acquired an equity stake in Instalimb Inc. in February 2024 to support global expansion of affordable 3D-printed prosthetic devices. North America held the largest market share in 2024, with Asia-Pacific expected to be the fastest-growing region through the forecast period.